Act Wealth Management, LLC Alaunos Therapeutics, Inc. Transaction History

Act Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$0.46 - $0.81 $17,698 - $31,165	38,476 New	38,476 $24,000
Q3 2022 Oct 24, 2022	BUY	$1.04 - $322.5 $1,461 - $453,112	1,405 Added 3.79%	38,476 $66,000
Q4 2021 Jan 31, 2022	BUY	$1.09 - $1.89 $2,852 - $4,946	2,617 Added 7.6%	37,071 $40,000
Q2 2021 Jul 20, 2021	BUY	$2.63 - $3.67 $1,875 - $2,616	713 Added 2.11%	34,454 $91,000
Q1 2021 Apr 08, 2021	BUY	$2.82 - $5.6 $3,234 - $6,423	1,147 Added 3.52%	33,741 $121,000
Q4 2020 Feb 03, 2021	BUY	$2.09 - $3.09 $68,121 - $100,715	32,594 New	32,594 $82,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Act Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Act Wealth Management, LLC with notifications on news.